In addition, the blockade of type 1 immune response (Tsukamoto et al., 2018), elevation of Treg cells (Kato et al., 2018), expansion of MDSCs, and activation of stromal fibroblasts could also be induced by IL-6, thus contributing to tumor development (Hanazawa et al., 2018). The gene discussed is IL6; the disease is neoplasm.